Welcome to the Coriell Personalized Medicine Collaborative Research Study

Personalized medicine combines a patient’s genomic information with their family history, lifestyle, and environmental factors to make better predictions about their risk for disease or response to prescription drugs and to tailor treatments for their improved health.

To explore the use of genomic information in clinical decision-making, the Coriell Personalized Medicine Collaborative® (CPMC®) was initiated in 2007. This forward-looking research study is a multi-party endeavor of volunteer study participants, physicians, scientists, ethicists, genetic counselors, pharmacists, information technologists, and hospital and academic partners. Thousands of CPMC study participants have viewed their genetic and non-genetic risks for disease and drug response. How their lifestyle behaviors change, whether they choose to share their results and with whom is revealing the utility of genetic information in clinical care.

Welcome to the CPMC Study website. Explore to learn more about the future of healthcare.


COLLABORATIVE PARTNERS:

CPMC STUDY NEWS

The CPMC Study Experience:
DNA & Me
In the November edition of NJ Monthly, writer Ken Schlager shares his experience as a Coriell Personalized Medicine Collaborative study participant. Mr. Schlager discusses his customized risk reports for complex diseases and medication response, how they surprised him, and what he learned from them.
Read More >

MORE NEWS >>



SIGN IN TO MY ACCOUNT

Access your personal account.

VIEW SAMPLE RESULTS

See how the CPMC study returns risk information.

SUPPORT THE STUDY

Take the first step. Support Personalized Medicine.


FOR PHYSICIANS

Involvement of medical professionals is essential to improving our understanding of the efficacy of CPMC [Learn More]